ResultsIQ

ResultsIQ › Latest results › Mahamaya Lifesciences Ltd

Mahamaya Lifesciences Ltd investor presentation summary

NSE: MAHALIFE · BSE: 544611

Investor presentation of 7 Aug 2026, summarised by AI from the filing.

Mahamaya Lifesciences filed its investor meet presentation with BSE; the meet is on August 07, 2026, from 04:00 pm IST.

Key takeaways

  1. Investor meet The investor meet is scheduled for Friday, August 07, 2026, from 04:00 pm (IST) onwards.
  2. Presentation The investor presentation to be shared at the meet is available on the company's website.
  3. Disclosure The presentation is shared for dissemination of information and does not contain any unpublished price sensitive information.
  4. Filing The filing is under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Part A of Schedule III.
  5. Signatory Krishnamurthy Ganesan, Managing Director, DIN: 00270539, signed the filing for Mahamaya Lifesciences Limited.

Original filing on BSE

Mahamaya Lifesciences Ltd earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.